Announce Date | 05/06/2025 |
EPS Normalized Actual | $2.82 (Beat by $0.13) |
EPS GAAP Actual | $2.82 (Beat by $0.13) |
Revenue Actual | $2.4121B |
Revenue Surprise | Beat by $2412.1M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 22.38 | 3.52 | 21.54731 | 23.18086 | 3 |
Dec 2028 | 10.42454 | 7.56 | 10.2716 | 10.85098 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.24 | 1.24 | 2.4121B | -0.34% | 2412.1M |
FQ4 2024 (Dec 2024) | 2.26 | 2.26 | 2.51539B | 3.24% | 2515.39M |
FQ3 2024 (Sep 2024) | 1.23 | 1.23 | 2.60155B | 4.84% | 2601.55M |
FQ2 2024 (Jun 2024) | 1.47 | 1.47 | 2.56877B | 4.53% | 2568.77M |
FQ1 2024 (Mar 2024) | 1.22 | 1.22 | 2.42019B | 5.28% | 2420.19M |
FQ4 2023 (Dec 2023) | 1.38 | 1.38 | 2.43381B | 7.43% | 2433.81M |
FQ3 2023 (Sep 2023) | 1.39 | 1.39 | 2.47569B | 100% | 2475.69M |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 2.45247B | 100% | 2452.47M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 4.51 | -- | 4.40782 | 4.58192 | 7 |
FQ3 2028 (Sep 2028) | 4.62 | -- | 4.51533 | 4.69367 | 7 |
FQ2 2028 (Jun 2028) | 4.5 | -- | 4.39805 | 4.57176 | 7 |
FQ1 2028 (Mar 2028) | 4.08 | -- | 3.98757 | 4.14506 | 7 |
FQ4 2027 (Oct 2027) | 4.24 | -- | 4.1731 | 4.28682 | 9 |
FQ3 2027 (Jul 2027) | 3.74 | -- | 3.68099 | 3.7813 | 9 |
FQ2 2027 (Jun 2027) | 3.73 | -- | 3.70653 | 3.75291 | 9 |
FQ1 2027 (Mar 2027) | 3.23 | -- | 3.20967 | 3.24984 | 15 |
FQ4 2026 (Oct 2026) | 3.98214 | -- | 3.94893 | 4.01062 | 13 |
FQ3 2026 (Jul 2026) | 3.74944 | -- | 3.71817 | 3.77626 | 17 |
FQ2 2026 (Jun 2026) | 3.75081 | -- | 3.69129 | 3.82188 | 17 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Dec 2028) | 3.03B | -- | 2.97B | 3.06B | 7 |
FQ3 2028 (Sep 2028) | 3.06B | -- | 3B | 3.09B | 6 |
FQ2 2028 (Jun 2028) | 3.03B | -- | 2.98B | 3.07B | 5 |
FQ1 2028 (Mar 2028) | 2.86B | -- | 2.81B | 2.89B | 5 |
FQ4 2027 (Oct 2027) | 2.9B | -- | 2.86B | 2.92B | 11 |
FQ3 2027 (Jul 2027) | 2.82B | -- | 2.79B | 2.85B | 8 |
FQ2 2027 (Jun 2027) | 2.81B | -- | 2.8B | 2.83B | 9 |
FQ1 2027 (Mar 2027) | 2.65B | -- | 2.64B | 2.66B | 9 |
FQ4 2026 (Oct 2026) | 2.7B | -- | 2.69B | 2.72B | 9 |
FQ3 2026 (Jul 2026) | 2.62B | -- | 2.6B | 2.63B | 10 |
FQ2 2026 (Jun 2026) | 2.56B | -- | 2.53B | 2.6B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.24 | 1.24 | 100% | |
FQ4 2024 (Dec 2024) | 2.26 | 2.26 | 100% | |
FQ3 2024 (Sep 2024) | 1.23 | 1.23 | 100% | |
FQ2 2024 (Jun 2024) | 1.47 | 1.47 | 100% | |
FQ1 2024 (Mar 2024) | 1.22 | 1.22 | 100% | |
FQ4 2023 (Dec 2023) | 1.38 | 1.38 | 100% | |
FQ3 2023 (Sep 2023) | 1.39 | 1.39 | 100% | |
FQ2 2023 (Jun 2023) | 1.05 | 1.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.41B | $2412.1M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.52B | $2515.39M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.6B | $2601.55M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.57B | $2568.77M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.42B | $2420.19M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.43B | $2433.81M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.48B | $2475.69M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.45B | $2452.47M | 100% |